1. Short title
This Act may be cited as the “Ending Discrimination in COVID–19 Treatments Act”.
Ending Discrimination in COVID–19 Treatments Act
A BILL
To prohibit the consideration of patients' race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, or political ideology or speech in determining eligibility for monoclonal antibody doses distributed by the Federal Government.
2. Eligibility to receive monoclonal antibody treatment
The Secretary of Health and Human Services shall require States, as a condition for receipt of monoclonal antibody doses from the Federal Government, to ensure that providers receiving distributions of such monoclonal antibody doses from such States do not take into consideration the race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, or political ideology or speech of a patient in determining whether a patient is eligible to receive such treatment.